文献速递小儿骨科骨质疏松与代谢性骨病创伤骨科

杜氏肌营养不良症骨病负担:骨质疏松与低骨密度的年龄别患病率

The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density.
PubMed 文献 · Osteoporos Int · 2026-03-30

该回顾性研究纳入408例每日接受糖皮质激素治疗的杜氏肌营养不良症(DMD)患儿,评估骨质疏松和骨折的年龄相关患病率。骨质疏松患病率在5岁、10岁和18岁时分别为4.4%、20.9%和58.3%,长骨和/或椎体骨折患病率分别为16.5%、37.4%和83.3%。低全身骨密度Z值先于临床可检测的骨质疏松出现,而腰椎值滞后。

要点

  • DMD患儿骨质疏松患病率随年龄和糖皮质激素暴露增加而上升。
  • 5岁、10岁、18岁时骨质疏松患病率分别为4.4%、20.9%、58.3%。
  • 低全身骨密度Z值可能预示临床可检测的骨质疏松。

核心结论

  • DMD儿童和青少年中骨质疏松、骨折和低骨密度从幼龄即高度流行,并随年龄和糖皮质激素暴露逐渐增加。

研究设计与样本

  • 回顾性研究,纳入美国辛辛那提儿童医院综合神经肌肉中心9年间就诊的408例每日接受糖皮质激素治疗的DMD患者,平均年龄8.0±3.5岁(范围3.0-19.3岁),糖皮质激素起始平均年龄6.4±2.5岁,平均疗程2.7±2.4年。

主要发现

  • 骨质疏松患病率在5岁、10岁和18岁时分别为4.4%、20.9%和58.3%。
  • 长骨和/或椎体骨折患病率在5岁、10岁和18岁时分别为16.5%、37.4%和83.3%。
  • 低全身骨密度Z值先于临床可检测的骨质疏松出现,而低腰椎骨密度值滞后。

临床怎么用

  • 对每日接受糖皮质激素治疗的DMD患儿应关注骨健康,监测骨折史、脊柱影像和骨密度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We evaluated fracture and osteoporosis prevalence in a large cohort of children with DMD undergoing routine spine imaging. Osteoporosis is common and worsens with age and glucocorticoid use. Low total body bone mineral density may herald clinically detectable osteoporosis. Our findings emphasize the need for better detection and prevention. INTRODUCTION: Osteoporosis is a major health concern in individuals with Duchenne muscular dystrophy (DMD) due to long-term glucocorticoid (GC) therapy, muscle weakness and restricted mobility. Osteoporosis results in long bone and vertebral fractures, which can lead to significant morbidity including premature loss of ambulation. We evaluated the age-related prevalence of osteoporosis and bone health indices in children and adolescents with DMD on daily GC therapy. METHODS: We conducted a retrospective review of patients with DMD seen at Cincinnati Children's Comprehensive Neuromuscular Center over 9 years. Bone health assessments included fracture history, routine annual spine radiographs and bone mineral density (BMD) by dual-energy X-ray absorptiometry. RESULTS: We included 408 patients with DMD (mean age 8.0 ± 3.5 years, range 3.0-19.3 years) who had received daily GC (mean age of GC start 6.4 ± 2.5 years, mean duration 2.7 ± 2.4 years). Osteoporosis prevalence increased progressively with age: 4.4%, 20.9%, and 58.3% at ages 5, 10 and 18 years, respectively. The prevalence of long bone and/or vertebral fractures was 16.5%, 37.4%, and 83.3%, respectively. Low total body BMD Z-scores preceded clinically detectable osteoporosis, while low lumbar spine values lagged behind. CONCLUSIONS: Osteoporosis, fractures, and low BMD were highly prevalent from a young age in children and adolescents with DMD and increased progressively with age and GC exposure. The prevalence of osteoporosis reflected the cumulative acquisition of vertebral fractures, consistent with long-term GC effect. These data highlight the urgent need to improve early detection and prevention of osteoporosis in individuals with DMD.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Nasomyont N, Tian C, Hornung L, et al. The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density. Osteoporos Int. 2026. PMID: 41912872. doi:10.1007/s00198-026-07963-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。